The world’s most expensive drug is not a drug

Reports have appeared in the media recently headlining “the world’s most expensive drug” The subject of these headlines is Libmeldy, but the media seems obsessed with its cost, rather than what Libmeldy actually is. And, by the way, Libmeldy is no more a drug than my bird-watching binoculars are the James Web Space Telescope, butContinue reading “The world’s most expensive drug is not a drug”

Spinal muscular atrophy and Zolgensma

Reports have appeared in the UK media of the NHS administering the most expensive drug in the world to a 5-month-old boy. Onasemnogene abeparvovec (sold as Zolgensma), costing around two and a half million US-dollars (£1.79 million),* is a gene therapy agent to treat spinal muscular atrophy. The headlines quoted the price but gave scantContinue reading “Spinal muscular atrophy and Zolgensma”